Abstract
Acute myeloid leukaemia (AML) is the most common leukaemia in adults with a mean age at presentation between 65 to 72 years. During the first two decades of the 21st century we witnessed vast developments in the molecular pathogenesis of AML and the translation of these discoveries to clinical practice. The year 2022 saw the publication of three pivotal consensus papers on the classification and management of AML.
DOI: https://doi.org/10.4038/tsljh.v14i1.1 | Journal eISSN: 1391-7919
Language: English
Page range: 1 - 4
Published on: Dec 31, 2022
Published by: The Sri Lanka College of Haematologists
In partnership with: Paradigm Publishing Services
Keywords:
© 2022 M Wimalachandra, L Gooneratne, published by The Sri Lanka College of Haematologists
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.